DT Cloud Acquisition Corporation (NASDAQ:DYCQU, DYCQ, DYCQR))))) ("DT Cloud" or the "SPAC"), a publicly-traded special purpose acquisition company, and Maius Pharmaceutical Co., Ltd. ("Maius" or the "Company"), a biopharmaceutical R&D company, announced that they had entered into a definitive business combination agreement (the "Business Combination Agreement") for the merger transactions (the "Business Combination," and the transactions in connection with the Business Combination collectively, the "Transaction"). As contemplated in the Business Combination Agreement, upon closing of the Transaction, Maius will become a wholly-owned subsidiary of Maius Pharmaceutical Group Co., Ltd., a newly formed holding company ("Pubco"), the securities of which will be listed on The Nasdaq Stock Market LLC ("Nasdaq").